Peter Maag compensation by year
CareDx Summary Compensation Table · all 4 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Salary | $450,000 | $483,750 | $510,030 | $488,700 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $306,900 | $2,728,322 | $6,673,480 | $3,327,600 |
| Option awards | $264,837 | $1,324,759 | $1,670,674 | $1,721,935 |
| Non-equity incentive | $378,000 | $693,000 | $568,339 | $860,220 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $1,560 | $1,560 | $1,560 | $1,560 |
| Total | $1,401,297 | $5,231,391 | $9,424,083 | $6,400,015 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CareDx, Inc. DEF 14A filed April 30, 2021, accession 0001217234-21-000079, and prior-year filings. Open the filing on EDGAR.
How this page was built: the CareDx, Inc. filed document, accession 0001217234-21-000079. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.
Equity holdings
unvested awards at FY2020 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 40,000 | $1,379,600 | — |
| RSU | 37,500 | $1,035,375 | — |
| RSU | 36,000 | $978,120 | — |
| RSU | 40,000 | $974,000 | — |
| RSU | 40,000 | $974,000 | — |
| RSU | 75,000 | $918,000 | — |
| RSU | 22,212 | $140,158 | — |
| RSU | 4,500 | $10,350 | — |
| Option | 1,250 | — | $2.30 |
| Option | 3,125 | — | $2.80 |
| Option | 9,375 | — | $5.90 |
| Option | 50,000 | — | $27.17 |
Per the Outstanding Equity Awards at Fiscal Year-End table in CareDx, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 16 award rows shown.
Insider transactions since the last proxy
31 Form 4 lines since the FY2020 proxy (filed April 30, 2021)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2025-07-07 | Sale | — | 10,000 | $18.58 | 308,846 |
| 2025-06-17 | Sale | 10b5-1 | 10,000 | $19.24 | 318,846 |
| 2025-06-13 | Grant or award | — | 12,103 | $0.00 | 328,846 |
| 2025-04-30 | Sale | 10b5-1 | 13,281 | $17.23 | 316,743 |
| 2024-11-26 | Exercise or conversion | 10b5-1 | 5,000 | $12.24 | 335,024 |
| 2024-11-26 | Sale | 10b5-1 | 5,000 | $25.00 | 330,024 |
| 2024-11-26 | Exercise or conversion derivative | 10b5-1 | 5,000 | $0.00 | 1,250 |
| 2024-08-20 | Exercise or conversion | — | 26,708 | $7.96 | 365,576 |
The 8 most recent of 31 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
CareDx’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Peter Maag · this page | Executive Chair and Former Chief Executive Officer | $6,400,015 |
| MBBS Reginald Seeto | Chief Executive Officer, President and Chief Business Officer | $5,618,698 |
| Michael Bell | Former Chief Financial Officer (4) | $3,443,952 |
| Sasha King | Chief Marketing Officer | $1,541,104 |
| Marcel Konrad | Former Interim Chief Financial Officer | $953,469 |
Board service
CareDx board · FY2022–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $52,747 | $224,995 | $0 | $0 | $277,742 |
| FY2024 | $49,993 | $149,988 | $150,049 | — | $350,030 |
| FY2023 | $54,935 | $149,998 | $149,995 | — | $354,928 |
| FY2022 | $43,235 | $99,983 | $156,379 | — | $299,597 |
Each year as the company reported it in CareDx's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: CareDx pays directors a $50,000 cash retainer and $225,000 in RSUs. As stated in CareDx's FY2025 proxy.
Committees
Nominating/Governance · Technology and Innovation
The full CareDx compensation record
free company briefThis page is one person within CareDx's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CareDx proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CareDx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.